Figure 8.
BLI competition assay. (A) BLI measurements of tested CD4mcs competition with sCD4 binding to LMHT gp120CRF01_AE coree enables determination of the concentration required to outcompete 50% of CD4-Coree binding (C50). (B) Correlation of ADCC activity against HIV-1AD8 and C50 from the sCD4 competition assays. (C) Correlation of neutralization of HIVCH58TF (IC50) and C50 from the sCD4 competition assays.